Literature DB >> 97373

Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: Relationship to status of pulmonary disease in sibling pairs.

R U Sorensen, R C Stern, S H Polmar.   

Abstract

Lymphocyte proliferative responses to Pseudomonas aeruginosa and Staphylococcus aureus were evaluated in six sibling pairs with cystic fibrosis. In each pair, one sibling had advanced clinical disease, whereas the other sibling was in good clinical condition. Three in this latter group had no clinically apparent Pseudomonas bronchitis. In all cases, the average responses to Pseudomonas isolated from each sibling pair were lower in the sibling with advanced clinical disease. This difference was not observed in the responses to Staphylococcus. Normal plasma or plasma from patients with CF in good clinical condition does not restore the responses in patients with advanced clinical disease. However, plasma from patients with low or no responses to Pseudomonas inhibits the responses of responding siblings. A progressive specific lymphocyte unresponsiveness to Pseudomonas may play an important role in the increasing destructiveness of chronic pulmonary Pseudomonas infection in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97373     DOI: 10.1016/s0022-3476(78)80496-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Clinical relevance of raised soluble serum interleukin-2 receptor concentrations in cystic fibrosis.

Authors:  D Y Koller; M Götz
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

3.  Cell mediated immunity and suppressor T cell function in children with cystic fibrosis.

Authors:  T B Harper; H R Gaumer; W Waring; R B Brannon; J E Salvaggio
Journal:  Lung       Date:  1980       Impact factor: 2.584

4.  Functional activity of peripheral mononuclear cells in cystic fibrosis: antibodies and plaque formation.

Authors:  M Götz; C C Zielinski; R Ahmad; M Eibl
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

Review 5.  Immunological abnormalities in cystic fibrosis: chicken or egg?

Authors:  M E Hodson
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

6.  Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; P Chase; S H Polmar
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

Review 7.  Vaccines for Pseudomonas aeruginosa: a long and winding road.

Authors:  Gregory P Priebe; Joanna B Goldberg
Journal:  Expert Rev Vaccines       Date:  2014-02-27       Impact factor: 5.217

Review 8.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

9.  Intact splenic function in cystic fibrosis.

Authors:  N J Barrios; M Kiernan; R Beckerman; S Davis
Journal:  J Natl Med Assoc       Date:  1994-04       Impact factor: 1.798

10.  In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa.

Authors:  M M Stevenson; T K Kondratieva; A S Apt; M F Tam; E Skamene
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.